Radiation therapy startup RayzeBio raises $108M


RayzeBio, a startup that is developing targeted radiopharmaceuticals to treat several types of cancer, raised $108 million in its Series C funding round. CEO and President Ken Song said the new capital will help the company become the leader in targeted radiopharmaceuticals.

Full story:

SNMMI SmartBrief

Nuclear medicine, molecular imaging and therapy

Designed specifically for nuclear medicine and molecular imaging professionals, SNMMI SmartBrief is a FREE, daily e-mail newsletter. It provides the latest news and information to save you time and keep you informed on our profession.